大麻二酚 CBD × 失眠

結論:主流反證據

The totality of evidence does not support pure CBD as an effective treatment for insomnia.

D 🔴 D 反證據 主流反證據 🚨 high — heavy affiliate marketing in TW community
⚠️ 標記 ⚠️ COI(產業聯盟資助) 🇹🇼 台灣在地警示 💊 檢驗 / 藥物交互作用

The totality of evidence does not support pure CBD as an effective treatment for insomnia. Both dedicated 150 mg pure-CBD primary-insomnia RCTs (n=30 each) were NULL on every primary insomnia outcome, and a 2025 meta-analysis of 6 RCTs (1077 patients) found that CBD-only therapies have NO statistically significant effect on subjective sleep quality, with the positive signal coming exclusively from THC/CBN-containing products. The American Academy of Sleep Medicine explicitly advises against routine cannabinoid use for any sleep disorder and notes a scoping review where 48% of studies reported worsening sleep versus only 21% reporting improvement. Examine has no CBD-insomnia outcome block at all (coverage gap), and Cleveland Clinic, Mayo Clinic researchers, and Harvard all characterise the evidence as inadequate or preliminary, with Harvard's mildly optimistic framing resting partly on cannabis/THC rather than pure-CBD data. Grade D is assigned because the best-quality, condition-specific pure-CBD evidence is negative-to-negligible, a recognised authority actively discourages use, and CBD additionally carries serious drug-interaction and hepatotoxicity risks (L9) plus prescription-only / unlawful-as-food regulatory status in Taiwan, the US and the EU. A C grade would overstate a body of evidence whose dedicated trials all failed.

⚖️

評分透明度

所有分數由 7 層證據引擎計算,過程公開可查
原始分數 0.39
D
C
B
A
S
← 反證據 / 無效有效 / 強證據 →
最終評級
D · 主流反證據
信心度
75%
證據方向大致一致
證據層級
E2
多篇高品質統合分析(≥2 篇一致)

各層「支持此療效」的程度

分數越低=該層越不支持
L11 AI 複核獨立判讀
0.30
L5 臨床機構權威立場
0.32
L2 PubMed原始文獻
0.45
L3 機轉生理合理性
0.45
L1 Examine國際基準
0.50
不支持 中性 / 混合 支持
查看完整決策路徑(audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.386
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高階證據未達主導 (1 positive vs 1 negative),由 raw_score 決定
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 0 個 hard + 1 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

Cannabidiol for moderate-severe insomnia: a randomized controlled pilot trial of 150 mg of nightly dosing
PMID: 38174873 2024 隨機對照試驗 n = 30
結論:In adults with moderate-severe primary insomnia, 150 mg pure CBD showed NO between-group difference vs placebo on insomnia severity, self-reported sleep-onset latency, sleep efficiency or wake after sleep onset (all p>0.05). Objective sleep efficiency improved modestly after 2 weeks (mean difference +6.85%, p<0.05) and well-being scores were higher with CBD (mean difference 2.60, p<0.05), but the primary insomnia outcomes were null.
🟠 品質有限 ⚠️ 廠商資助 效應量:Primary insomnia outcomes NS; objective sleep efficiency +6.85% (p<0.05)
前往 PubMed
The effect of nightly use of 150 mg cannabidiol on daytime neurocognitive performance in primary insomnia: a randomized controlled pilot trial
PMID: 39153080 2025 隨機對照試驗 n = 30
結論:Companion analysis of the same 150 mg CBD primary-insomnia cohort: nightly CBD did NOT impair daytime cognition (all p>0.05) and was associated with greater self-reported calmness, clear-headedness and coordination, plus more dry mouth. The study supports daytime safety but does not demonstrate a sleep benefit for insomnia.
🟠 品質有限 ⚠️ 廠商資助 效應量:Cognition unaffected; mood/calmness improved (p<0.05); dry mouth more common
前往 PubMed
Effects of a cannabidiol/terpene formulation on sleep in individuals with insomnia: a double-blind, placebo-controlled, randomized, crossover study
PMID: 39167421 2024 RCT (double-blind) n = 56
結論:A CBD/terpene formulation produced only a marginal increase in slow-wave + REM sleep (+1.3%, 95% CI 0.1-2.5%, p=0.03) and did NOT increase total sleep time. 125 enrolled but only 56 completed (high attrition). This is a CBD-plus-terpene product, not pure CBD, and the effect is small and of uncertain clinical relevance.
🟠 品質有限 ⚠️ 廠商資助 效應量:SWS+REM +1.3% (p=0.03); total sleep time unchanged
前往 PubMed
Acute Effects of Oral Cannabinoids on Sleep and High-Density EEG in Insomnia: A Pilot Randomised Controlled Trial
PMID: 40631525 2025 隨機對照試驗 n = 20
結論:A single THC+CBD combination dose WORSENED objective sleep in insomnia patients: total sleep time fell by 24.5 min and REM sleep fell by 33.9 min vs placebo, with delayed REM onset. Authors attribute the effect mainly to THC. This is a THC-containing product, not pure CBD, and illustrates that the cannabis/THC sleep signal can be negative.
🟠 品質有限 效應量:Total sleep time -24.5 min; REM -33.9 min (THC-driven)
前往 PubMed
Use of Cannabidiol in the Management of Insomnia: A Systematic Review
PMID: 36149724 2023 系統性回顧
結論:Mayo Clinic-authored systematic review of 34 studies. Among hypothesis-testing studies only 4 of 7 CBD-predominant arms showed significant insomnia improvement vs 12 of 16 near-equal CBD:THC arms. Critically, only 2 of 34 studies focused specifically on insomnia patients (one was a case report); most relied on non-validated subjective measures. Concludes CBD alone or with equal THC may help but rigorous insomnia-specific trials are needed.
效應量:CBD-predominant: 4/7 arms significant; near-equal CBD:THC: 12/16 significant
前往 PubMed
Effectiveness of cannabinoids on subjective sleep quality in people with and without insomnia or poor sleep: A systematic review and meta-analysis of randomised studies
PMID: 40929927 2025 統合分析 n = 1,077
結論:Meta-analysis of 6 RCTs (1077 patients). Cannabinoids overall improved subjective sleep quality, but the effect was driven by THC- and/or CBN-containing products: CBD-ONLY therapies showed NO statistically significant effect on sleep quality. This directly distinguishes pure-CBD evidence (null) from cannabis/THC evidence.
效應量:CBD-only: NS; THC/CBN-containing: significant improvement
前往 PubMed

L4a US FDA
反對
Today, the U.S. Food and Drug Administration announced that the agency has concluded that a new regulatory pathway for CBD is needed... the agency has concluded that existing regulatory frameworks for foods and supplements are not appropriate for CBD. 來源↗
L4b EU EFSA
反對
L4c UK NHS
謹慎
Healthy adults should think carefully before taking CBD, and should consider limiting their consumption of CBD from food to no more than 10mg per day, which is about 4-5 drops of 5% CBD oil. The FSA continues to advise that CBD is not taken by people in vulnerable groups, including children, people taking medication and those who are pregnant or breastfeeding and those trying to conceive. 來源↗
L4d TW TFDA / 衛福部
反對
大麻二酚(CBD)不屬於毒品及管制藥品,考量其具有非常多藥理活性及可能的醫療用途,我國以一般藥品列管。 來源↗
L4e WHO
未表態
In general, CBD is well tolerated with a good safety profile... To date, there is no evidence of recreational use of CBD or any public health-related problems associated with the use of pure CBD. [WHO ECDD Cannabidiol (CBD) Critical Review Report, June 2018] 來源↗

L5a NIH Office of Dietary Supplements
謹慎
L5b Mayo Clinic
謹慎
CBD is often used by patients for the management of insomnia, yet research supporting CBD's effectiveness as a treatment for insomnia is inadequate. 來源↗
L5c Cleveland Clinic
謹慎
L5d Harvard Health
謹慎
L5e Specialty Society (condition-mapped)
反對

PTT · Dcard · Mobile01 彙整自公開論壇討論,非統計抽樣,僅反映社群風向。
廣告 / 業配密度 極高
📍立場總覽

PTT(Health/MuscleBeach/MenTalk)與 Dcard 社群對 CBD 助眠討論熱絡,部分人反映半小時內入睡、夜間醒來次數大減、長輩睡得深,回饋偏正面;但也有健身族指台灣合法純 CBD 效果「微妙」、時有時無,且須海外代購、單價高,整體經驗分歧、業配密度高。

💬社群實感

分歧(助眠回饋偏正面,但台灣合法純 CBD 多人反映效果微妙或無感,且屬個人經驗、非研究證據)

破解迷思 社群最常見的 5 個誤解
迷思誤把 CBD 等同會「飛高高」的大麻(THC)
事實CBD 單獨使用不具精神活性,社群多次澄清
事實誤以為台灣可合法生產販售 CBD 保健品(實際僅允許 THC<10ppm 純 CBD 個人海外代購,國內禁止製造買賣)
事實誤以為國外那種強效助眠是 CBD 的功勞(社群指真正有感者多為含 THC 之全光譜產品,台灣合法純 CBD 缺乏共伴效應、效果較弱)
事實把社群個人助眠心得當作療效實證(屬 anecdotal,不能取代研究證據與就醫)
事實誤以為 CBD 寢具/枕頭具有等同口服的助眠藥理作用(多屬行銷話術)
🩹 社群通報的副作用
  • 嗜睡、隔日易睡過頭(需設鬧鐘)
  • 初次過量產生不適或過 high 感(多見於併用 THC 全光譜時)
  • 部分人反映無感或反而較難入睡(效果因人而異)

查看代表討論串 ↗

L10a · 廠商行銷話術 行銷語言
💬 通路如何宣傳

市面上販售的 CBD 軟糖、巧克力、餅乾等都是違法販售的;CBD 在我國不得供食品原料使用

代表來源 ↗
L10b · TFDA 法定身份 官方認定

倘將 CBD 供作食品用途,即違反食品安全衛生管理法第15條第1項第9款規定,得依同法第44條規定處新臺幣6萬元以上2億元以下罰鍰

來源 ↗

  • 失眠認知行為治療(CBT-I)
  • 睡眠衛生與刺激控制
PMID 100% 反查全部經 NCBI Entrez 驗證
🔬 6 篇 L2 文獻 經多層 sub-agent 獨立評估
🇹🇼 含台灣社群分析L10c PTT / Dcard / Mobile01
aggregated_at: 2026-06-01 claim_version: v25 engine_version: v1.0 claim_id: CLM-COND-insomnia-INT-cannabidiol-001
查看 ClaimReview 結構化資料 (JSON-LD)
{
  "@context": "https://schema.org",
  "@type": "ClaimReview",
  "url": "https://gpt-dict.com/claim/CLM-COND-insomnia-INT-cannabidiol-001/",
  "datePublished": "2026-06-01",
  "author": {
    "@type": "Organization",
    "name": "gpt-dict.com",
    "url": "https://gpt-dict.com"
  },
  "claimReviewed": "大麻二酚能改善失眠",
  "inLanguage": "zh-TW",
  "itemReviewed": {
    "@type": "Claim",
    "appearance": []
  },
  "reviewRating": {
    "@type": "Rating",
    "ratingValue": 1,
    "bestRating": 5,
    "worstRating": 1,
    "alternateName": "🔴 D 反證據"
  }
}